Announcements Trials
Browse Landscape

Status

Unknown 2Recruiting 2Terminated 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 29Observational 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Colorectal Neoplasms 14Carcinoma, Hepatocellular 5Liver Neoplasms 3Gastrointestinal Stromal Tumors 2TAS 102 1Neoplasms 1Neoplasm Metastasis 1Metastatic Colorectal Adenocarcinoma 1Glioblastoma 1Colonic Neoplasms 1COVID-19 1Advanced Gastrointestinal Stromal Tumor 1Advanced Colorectal Carcinoma 1

Interventions

Sorafenib 20lenvatinib 18Hepatectomy 17Blood Specimen Collection 12Immune Checkpoint Inhibitors 11Liver Transplantation 9atezolizumab 8Surgical Procedures, Operative 7Radiofrequency Ablation 7Observation 7Bevacizumab 6regorafenib 5gadolinium ethoxybenzyl DTPA 5sintilimab 4donafenib 4camrelizumab 4Radiotherapy 4Magnetic Resonance Spectroscopy 4tislelizumab 3spartalizumab 3Polymerase Chain Reaction 3Neoadjuvant Therapy 3Mass Spectrometry 3Immunohistochemistry 3Doxorubicin 3Angiogenesis Inhibitors 3toripalimab 2pembrolizumab 2entecavir 2apatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Carcinoma, Hepatocellular × regorafenib × Clear all
NCT05713994 2025-03-25

CCGLC-001

Tongji Hospital

Recruiting
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05717738 2024-06-13

CCGLC-008

Tongji Hospital

Recruiting
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05811481 2023-04-13

ROSE

First Affiliated Hospital, Sun Yat-Sen University

Unknown
192 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05557656 2022-12-29

A Real World Study of Regogfinib in HCC

Zhongda Hospital

Unknown
800 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03644511 2020-08-21

SORAGO-HCC

Bayer

Terminated
3 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡